Loading
A phase 2 trial of Temoporfin in Head and neck squamous cell carcinoma, run by University of Arkansas, recorded as terminated on the registry.
Interstitial Photodynamic Therapy (PDT) With Temoporfin for Advanced Head and Neck Cancers is a phase 2 interventional study registered as NCT01415986 by University of Arkansas, with 1 participants recorded, started 2010-11 and due to reach its primary completion in 2011-08. Interventions recorded: Temoporfin, Medical diode laser emitting light at a wavelength of 652 nm. (Ceralas PDT 652, CeramOptec GmbH). Conditions recorded: Squamous Cell Carcinoma of the Head and Neck.
Linked to the drug Temoporfin because the registry names it among its interventions and Head and neck squamous cell carcinoma among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Temoporfin and the tag pipeline.
Shares Temoporfin and the tag pipeline.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/